Yıl: 2022 Cilt: 9 Sayı: 3 Sayfa Aralığı: 152 - 158 Metin Dili: İngilizce DOI: 10.5606/e-cvsi.2022.1368 İndeks Tarihi: 30-10-2022

The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients

Öz:
Objectives: In the present study, we investigated the relationship between mentioned markers and chronic total occlusion collateral development. Patients and methods: A total of 243 patients (210 males, 33 females; mean age: 63.3±11.5; range, 51 to 76 years) who underwent coronary angiography due to typical chest pain or myocardial ischemia detected in noninvasive stress tests and diagnosed with ≥1 major coronary artery occlusion between January and September 2020 were included in the cross-sectional observational study. The angiographic collateral index was determined according to the Cohen-Rentrop classification. The patients were divided into two groups according to the sufficiency of collateral development: the well-developed collaterals group (n=155) and the poor-developed collaterals group (n=88). Results: Statistically significant parameters in univariate logistic regression analysis were evaluated with multivariate (stepwise) logistic regression analysis; as a result, presence of chronic total occlusion in left anterior descending artery (odds ratio [OR]=2.447; 95% confidence interval [CI], 1.160-5.162; p=0.019), total number of occlusions (OR=3.503; 95% CI, 1.445-8.494; p=0.006), left ventricular ejection fraction (OR=1.056; 95% CI, 1.022-1.091; p=0.001), and the atherogenic index of plasma (OR=0.017; 95% CI, 1.022-1.091; p<0.001) were independently associated with well-developed collaterals. Although the triglyceride-glucose index had statistical significance in the univariate analysis, it was not detected as an independent variable in the multivariate analysis. The monocyte-lymphocyte ratio was not significant in the univariate analysis. Conclusion: Of the new atherosclerosis markers, only the atherogenic index of plasma had an independent association with poor collateral development.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hansen JF. Coronary collateral circulation: Clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989;117:290-5.
  • 2. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991;83:739-46.
  • 3. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: Risk factors and the vascular endothelium. Am Heart J 1996;131:379-84.
  • 4. Abaci A, Oğuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-42.
  • 5. Turhan H, Erbay AR, Yasar AS, Bicer A, Sasmaz H, Yetkin E. Impaired coronary blood flow in patients with metabolic syndrome: Documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method. Am Heart J 2004;148:789-94.
  • 6. Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011;17:1410-22.
  • 7. Emamalipour M, Seidi K, Jahanban-Esfahlan A, Jahanban Esfahlan R. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines. J Cell Physiol 2019;234:21758-69.
  • 8. Cai G, Liu W, Lv S, Wang X, Guo Y, Yan Z, et al. Gender specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: A hospital-based observational study. Lipids Health Dis 2019;18:99.
  • 9. Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol 2020;19:8.
  • 10. Xiang F, Chen R, Cao X, Shen B, Liu Z, Tan X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study. Hemodial Int 2018;22:82-92.
  • 11. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-77.
  • 12. Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci 2010;10:248-52.
  • 13. Dobiásová M. AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice. Vnitr Lek 2006;52:64-71.
  • 14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
  • 15. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; A new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001;49:543-53.
  • 16. Sasmaz H, Yilmaz MB. Coronary collaterals in obese patients: Impact of metabolic syndrome. Angiology 2009;60:164-8.
  • 17. Liu T, Wu Z, Liu J, Lv Y, Li W. Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study. Cardiovasc Diabetol 2021;20:104.
  • 18. Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol 2018;17:121.
  • 19. Allahwala UK, Khachigian LM, Nour D, Ridiandres A, Billah M, Ward M, et al. Recruitment and maturation of the coronary collateral circulation: Current understanding and perspectives in arteriogenesis. Microvasc Res 2020;132:104058.
  • 20. Liu Z, Pericak-Vance MA, Goldschmidt-Clermont P, Seo D, Wang L, Rundek T, et al. Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients. PLoS One 2017;12:e0183836.
  • 21. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26.
  • 22. Shu W, Jing J, Fu LC, Min JT, Bo YX, Ying Z, et al. The relationship between diastolic pressure and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Am J Hypertens 2013;26:630-5.
  • 23. Schaper W, Sharma HS, Quinkler W, Markert T, Wünsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 1990;15:513-8.
  • 24. Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): A novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis 2018;17:197.
  • 25. Guo Q, Zhou S, Feng X, Yang J, Qiao J, Zhao Y, et al. The sensibility of the new blood lipid indicator--atherogenic index of plasma (AIP) in menopausal women with coronary artery disease. Lipids Health Dis 2020;19:27.
  • 26. Süleymanoğlu M, Rencüzoğulları İ, Karabağ Y, Çağdaş M, Yesin M, Gümüşdağ A, et al. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2020;36:789-96.
  • 27. Liu T, Liu J, Wu Z, Lv Y, Li W. Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography. Clin Cardiol 2021;44:518- 25.
  • 28. Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti inflammatory effects of high density lipoproteins. Curr Med Chem 2009;16:667-75.
  • 29. Murphy AJ, Woollard KJ. High-density lipoprotein: A potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 2010;37:710-8.
  • 30. Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep 2019;9:6129.
  • 31. da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol 2019;18:89.
  • 32. Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis 2018;10:6137-46.
  • 33. Novo G, Manno G, Russo R, Buccheri D, Dell'Oglio S, Morreale P, et al. Impact of insulin resistance on cardiac and vascular function. Int J Cardiol 2016;221:1095-9.
  • 34. Montecucco F, Steffens S, Mach F. Insulin resistance: A proinflammatory state mediated by lipid induced signaling dysfunction and involved in atherosclerotic plaque instability. Mediators Inf lamm 2008;2008:767623.
  • 35. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018;17:122.
  • 36. Wen Y, Zhan X, Wang N, Peng F, Feng X, Wu X. Monocyte/ lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients. Mediators Inflamm 2020;2020:9852507.
  • 37. Shaw DM, Merien F, Braakhuis A, Dulson D. T-cells and their cytokine production: The anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine 2018;104:136-42.
  • 38. Register TC, Appt SE, Clarkson TB. Atherosclerosis and vascular biologic responses to estrogens: Histologic, immunohistochemical, biochemical, and molecular methods. Methods Mol Biol 2016;1366:517-32.
  • 39. Melidonis A, Tournis S, Kouvaras G, Baltaretsou E, Hadanis S, Hajissavas I, et al. Comparison of coronary collateral circulation in diabetic and nondiabetic patients suffering from coronary artery disease. Clin Cardiol 1999;22:465-71.
APA emlek n, Özyıldız A, Ergül E, Öğütveren M, ÖZTÜRK M, AYDIN C (2022). The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. , 152 - 158. 10.5606/e-cvsi.2022.1368
Chicago emlek nadir,Özyıldız Ali Gökhan,Ergül Elif,Öğütveren Muhammed Mürsel,ÖZTÜRK Muhammet,AYDIN Cihan The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. (2022): 152 - 158. 10.5606/e-cvsi.2022.1368
MLA emlek nadir,Özyıldız Ali Gökhan,Ergül Elif,Öğütveren Muhammed Mürsel,ÖZTÜRK Muhammet,AYDIN Cihan The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. , 2022, ss.152 - 158. 10.5606/e-cvsi.2022.1368
AMA emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. . 2022; 152 - 158. 10.5606/e-cvsi.2022.1368
Vancouver emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. . 2022; 152 - 158. 10.5606/e-cvsi.2022.1368
IEEE emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C "The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients." , ss.152 - 158, 2022. 10.5606/e-cvsi.2022.1368
ISNAD emlek, nadir vd. "The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients". (2022), 152-158. https://doi.org/10.5606/e-cvsi.2022.1368
APA emlek n, Özyıldız A, Ergül E, Öğütveren M, ÖZTÜRK M, AYDIN C (2022). The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. Cardiovascular surgery and interventions, 9(3), 152 - 158. 10.5606/e-cvsi.2022.1368
Chicago emlek nadir,Özyıldız Ali Gökhan,Ergül Elif,Öğütveren Muhammed Mürsel,ÖZTÜRK Muhammet,AYDIN Cihan The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. Cardiovascular surgery and interventions 9, no.3 (2022): 152 - 158. 10.5606/e-cvsi.2022.1368
MLA emlek nadir,Özyıldız Ali Gökhan,Ergül Elif,Öğütveren Muhammed Mürsel,ÖZTÜRK Muhammet,AYDIN Cihan The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. Cardiovascular surgery and interventions, vol.9, no.3, 2022, ss.152 - 158. 10.5606/e-cvsi.2022.1368
AMA emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. Cardiovascular surgery and interventions. 2022; 9(3): 152 - 158. 10.5606/e-cvsi.2022.1368
Vancouver emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients. Cardiovascular surgery and interventions. 2022; 9(3): 152 - 158. 10.5606/e-cvsi.2022.1368
IEEE emlek n,Özyıldız A,Ergül E,Öğütveren M,ÖZTÜRK M,AYDIN C "The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients." Cardiovascular surgery and interventions, 9, ss.152 - 158, 2022. 10.5606/e-cvsi.2022.1368
ISNAD emlek, nadir vd. "The association of new atherosclerosis markers with coronary collaterals in chronic total occlusion patients". Cardiovascular surgery and interventions 9/3 (2022), 152-158. https://doi.org/10.5606/e-cvsi.2022.1368